Cell-Free Therapies: The Use of Cell Extracts to Mitigate Irradiation-Injured Salivary Glands

The document reviewed the potential of cell-free therapies, specifically cell extracts (CEs), to treat irradiation-injured salivary glands (SGs), a common issue in head and neck cancer patients post-radiotherapy. Traditional treatments were largely ineffective in reversing SG damage. CEs, derived from various cell types, offered a regenerative approach by utilizing proteins and other cellular components to promote tissue repair. Bone marrow and adipose stem cell extracts showed promise in preserving SG function and reducing fibrosis. The study emphasized the need for optimizing CE administration, including dosage and timing, to enhance therapeutic efficacy. Despite challenges like unknown mechanisms and the need for standardization, CEs were proposed as a safer and more practical alternative to cell-based therapies, with advantages such as reduced immune reactions and easier storage. Further research was necessary to fully understand and optimize CE therapy for clinical use.